Neoadjuvant Chemotherapy With Nab-paclitaxel Plus Cisplatin for Stage Ⅱ-Ⅲ Esophageal Cancer Patients
Status:
Completed
Trial end date:
2012-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and safety of neoadjuvant chemotherapy
with nab-paclitaxel plus cisplatin for stage Ⅱ-Ⅲ esophageal squamous cell carcinoma patients.
Phase:
Phase 2
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Collaborator:
Second Affiliated Hospital, School of Medicine, Zhejiang University